In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

EP Europace Journal

Covering the fields of arrhythmias, pacing and cellular electrophysiology

 

The EP-Europace journal aims to provide an avenue of communication of top quality European and international original scientific work and reviews in the fields of Arrhythmias, Pacing and Cellular Electrophysiology. The Journal offers the reader a collection of contemporary original peer-reviewed papers, invited papers and editorial comments together with book reviews and correspondence.  

Official journal of the European Heart Rhythm Association (EHRA), The ESC Working Group on Cardiac Cellular Electrophysiology, and The ESC Working Group on e-Cardiology

Fast Facts

  • Editor-in-Chief: G. Hindricks, FESC (Germany)
  • Current volume: 20 (year 2018)
  • Issues per subscription: 12
  • Impact Factor 2017: 5.231
Updates on latest articles

Updates on latest articles

 

Receive Table of contents in your mailbox.

Track the topics, authors and articles important to you and receive articles in your mailbox.

For Authors

Before being published, all manuscripts go through double-blinded peer review by experienced international experts.


Most recent articles from EP Europace

12 Oct 2018
Comment on ‘Antiarrhythmic drugs–clinical use and clinical decision making: a consensus document from EHRA’
Author(s):Milicevic G.
09 Jul 2018
Successful implantation of subcutaneous implantable cardioverter-defibrillator in a patient with severe pectus excavatum
Author(s):Karvouni E, Zografos T, Winter J, et al.
12 Oct 2018
Antiarrhythmic drugs–clinical use and clinical decision making: a consensus document from EHRA and ESC WG on Cardiovascular Pharmacology endorsed by HRS, APHRS, and ISCP—Authors’ reply
Author(s):Dan G, Martinez-Rubio A.
26 Jun 2018
Cardiac resynchronization therapy in heart failure: is the defibrillator needed?
Author(s):Dagres N, Hindricks G.